KeyBanc Cuts Acadia Healthcare (ACHC) PT to $30 from $35, Maintains Overweight on Q3 Results

Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the cheap US stocks to buy according to analysts. On November 18, KeyBanc lowered the firm’s price target on Acadia Healthcare to $30 from $35, while maintaining an Overweight rating on the shares. This sentiment was posted as KeyBanc cited the company’s Q3 2025 results and updated guidance.

In its Q3 2025 earnings report, Acadia Healthcare reported a 4.4% increase in revenue for the quarter, which totaled $851.6 million. This was supported by initiatives, such as a 3% same facility admissions growth driven by targeted improvements in acute care referral sources. The company also earned $0.72 per share, which also beat estimates by $0.06.

KeyBanc Cuts Acadia Healthcare (ACHC) PT to $30 from $35, Maintains Overweight on Q3 Results

However, the company’s adjusted EBITDA for Q3 fell to $173 million from $194.3 million in the prior year period, primarily due to softer-than-expected volumes in the Medicaid business and increased payer friction. Consequently, Acadia was compelled to reduce its Adjusted EBITDA guidance for 2025 to a range of $650 to $660 million, down from the previously issued guidance of $675 to $700 million.

Acadia Healthcare Company Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the US and Puerto Rico.

While we acknowledge the potential of ACHC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ACHC and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.